To develop an evidence-based clinical practice guideline for the prevention of oral mucositis in children (0-18 years) receiving treatment for cancer or undergoing haematopoietic stem cell transplantation (HSCT).
The Mucositis Prevention Guideline Development Group was interdisciplinary and included in...
La presente guía aborda el diagnóstico y tratamiento de la ansiedad en pacientes con cáncer y ofrece una serie de recomendaciones dirigidas a disminuir la variabilidad clínica, mejorar la calidad en la atención de la ansiedad en pacientes con cáncer....
Arends, J;
Bachmann, P;
Baracos, V;
Barthelemy, N;
Bertz, H;
Bozzetti, F;
Fearon, K;
Hütterer, E;
Isenring, E;
Kaasa, S;
Krznaric, Z;
Laird, B;
Larsson, M;
Laviano, A;
Mühlebach, S;
Muscaritoli, M;
Oldervoll, L;
Ravasco, P;
Solheim, T;
Strasser, F;
de, van, der, Schueren, M;
Preiser, JC.
Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise significantly over the next decades. At the same time, all types of cancer treatment, such as surgery, radiation therapy, and pharmacological therapies are improving in sophisticatio...
Dent, S;
Brezden-Masley, C;
Clarke, B;
Davis, MK;
Jassal, DS;
Johnson, C;
Lemieux, J;
Paterson, I;
Sebag, IA;
Simmons, C;
Sulpher, J;
Thain, K;
Thavendiranathan, P;
Wentzell, JR;
Wurtele, N;
Côté, MA;
Fine, NM;
Haddad, H;
Hayley, BD;
Hopkins, S;
Joy, AA;
Rayson, D;
Stadnick, E;
Straatman, L;
Virani, SA.
Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This ...
Antinéoplasiques,
Marqueurs biologiques,
Cardiotoniques,
Cardiotoxines,
Troponine T,
Peptide natriurétique cérébral,
Protéine C-réactive,
Antinéoplasiques/effets indésirables,
Troubles du rythme cardiaque,
Cardiotoxicité,
Thrombose coronarienne,
Diagnostic précoce,
Échocardiographie tridimensionnelle,
Hypertension artérielle/thérapie,
IRM dynamique,
Ischémie myocardique,
Tumeurs/thérapie,
Prévention primaire,
Radiothérapie,
Facteurs de risque,
Dysfonction ventriculaire gauche,
Cardiotoxicité/diagnostic,
Cardiotoxines/effets indésirables,
Radiothérapie/effets indésirables
The guideline was drafted by a writing group identified by the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology (BCSH). All the authors are consultants in haematology in the UK. A search was performed of PubMed and Embase using the term 'cancer' combined with 't...
Lehrnbecher, T;
Phillips, R;
Alexander, S;
Alvaro, F;
Carlesse, F;
Fisher, B;
Hakim, H;
Santolaya, M;
Castagnola, E;
Davis, B. L;
Dupuis, L. L;
Gibson, F;
Groll, A. H;
Gaur, A;
Gupta, A;
Kebudi, R;
Petrilli, S. L;
Steinbach, W. J;
Villarroel, M;
Zaoutis, T Sung.
To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient...
The first module in the Cancer Control series, Planning, provides a template for cancer control planning and progamme implementation. The recommended framework draws on earlier WHO work in this field, the principles of which are set out in National cancer control programmes, policies and managerial guide...
